NEWS & MEDIA
Featured
ASX News
Recommencement of ZIRCON Phase III Trial Recruitment in EU
Melbourne (Australia) – 18th June 2020. Telix Pharmaceuticals Limited announces that the Company’s ZIRCON phase III trial of TLX250-CDx has...
ASX News
Telix Granted FDA Breakthrough Therapy Designation for Renal Cancer Imaging Product
Melbourne (Australia) – 1st July 2020. Telix announces that the FDA has granted Breakthrough Therapy (BT) designation for Telix’s renal...
Corporate Spotlight
The Seneffe Manufacturing Site – Telix’s Next Big Move in Europe
1st May 2020 - Corporate Spotlight | Telix’s CEO Chris Behrenbruch comments on the Company’s next big move in Europe...
ASX News
Telix Pharmaceuticals and Pharmalogic Enter US Distribution Agreement for Prostate Cancer Imaging
Indianapolis IN and Boca Raton FL (U.S.A) – 15th May 2020. Telix Pharma (U.S.) announces it has entered into a commercial...
ASX News
Seneffe Manufacturing Facility – Shareholder Walkthrough
Melbourne (Australia) 28 April 2020 - Telix Pharmaceuticals Limited provides a shareholder walkthrough of it's recently acquired Seneffe manufacturing facility